LRP1B and Miyoshi myopathy: LRP1B is considered a putative tumor suppressor59-61 and is involved in the regulation of the Wnt/β-catenin/TCF signaling pathway.62 In the context of MM, the study by Corre et al63 identified LRP1B as one of the most frequently mutated genes in patients with MM (12% of the patients).